Serial administration of rhBMP-2 and alendronate enhances the differentiation of osteoblasts.

Sang-Hyon KimHye-Jung ChoiDae Sung YoonChang-Nam Son

Published in: International journal of rheumatic diseases (2021)

These findings indicate that the serial administration of rhBMP-2 and ALN may exert osteogenic effects on osteoblastic cells via the upregulation of Runx2 and OPN.

Keyphrases

induced apoptosis
cell cycle arrest
mesenchymal stem cells
recombinant human
signaling pathway
bone marrow
transcription factor
poor prognosis
cell proliferation
endoplasmic reticulum stress
cell death
vascular smooth muscle cells
oxidative stress
long non coding rna